In vivo therapy of myocardial infarction with mesenchymal stem cells modified with prostaglandin I synthase gene improves cardiac performance in mice

Life Sciences

Volumn 88, Issue 9-10, 2011, Pages 455-464

  Lian, Wei Shiung ^b,c   Cheng, Winston Teng Kuei ^d   Cheng, Chun Chun ^b   Hsiao, Felix Shih Hsiang ^b   Chen, Jin Jer ^c,e   Cheng, Ching Feng ^a,c,f   Wu, Shinn Chih ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d TUNGHAI UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Mesenchymal stem cell; Myocardial infarction; Paracrine factor; Prostacyclin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; FREE RADICAL; HYDROGEN PEROXIDE; LENTIVIRUS VECTOR; PROSTAGLANDIN SYNTHASE; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ECHOCARDIOGRAPHY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; REOXYGENATION; SPLEEN CELL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYCLOOXYGENASE 1; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; GENE THERAPY; MALE; MEMBRANE PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; SPLEEN; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

MUS;

EID: 79951950114     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.12.020     Document Type: Article

References (40)

1. Beeres SL, Bax JJ, Dibbets P, Stokkel MP, Zeppenfeld K, Fibbe WE, et al. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J Nucl Med 2006;47:574-80. (Pubitemid 46768457)
2. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-49. (Pubitemid 350127858)
3. Chen HH, Chen TW, Lin H. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia - reperfusion injury. Am J Physiol Ren Physiol 2009;297:F1109-18.
4. Chen M, Xie HQ, Deng L, Li XQ, Wang Y, Zhi W, et al. Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro. Cell Prolif 2008;41:336-47. (Pubitemid 351367494)
5. Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 2008;214:537-44. (Pubitemid 350309010)
6. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, Hervé P, et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003;108(Suppl. 1):II253-8.
7. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-44. (Pubitemid 37409409)
8. Freed DH, Cunnington RH, Dangerfield AL, Sutton JS, Dixon IM. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart. Cardiovasc Res 2005;65:782-92. (Pubitemid 40249724)
9. Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009;120:2077-87.
10. Gerber SA, Pober JS. IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. J Immunol 2008;181:1052-62.
11. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11:367-8. (Pubitemid 40562318)
12. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-9. (Pubitemid 44933310)
13. Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, de Boer RA, et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009;27:971-9.
14. Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, et al. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 2010;106:1753-62.
15. Ishii M, Numaguchi Y, Okumura K, Kubota R, Ma X, Murakami R, et al. Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia. Atherosclerosis 2009;206:109-18.
16. Kang JW, Kang KS, Koo HC, Park JR, Choi EW, Park YH. Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells. Stem Cells Dev 2008;17:681-93.
17. Kawakami T, Kanazawa H, Satoh T, Ieda M, Ieda Y, Kimura K, et al. AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice. Biochem Biophys Res Commun 2007;363:656-61. (Pubitemid 47513680)
18. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-56. (Pubitemid 43093128)
19. Lee IY, Bae YD, Jeoung DI, Kang D, Park CH, Kim SH, et al. Prostacyclin production is not controlled by prostacyclin synthase but by cyclooxygenase-2 in a human follicular dendritic cell line, HK. Mol Immunol 2007;44:3168-72. (Pubitemid 46610505)
20. Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006;70:530-42. (Pubitemid 43732376)
21. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-201. (Pubitemid 37173705)
22. Min JY, Sullivan MF, Yang Y, Zhang JP, Converso KL, Morgan JP, et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg 2002;74:1568-75. (Pubitemid 35222642)
23. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5. (Pubitemid 32290358)
24. Padin-Iruegas ME, Misao Y, Davis ME, Segers VF, Esposito G, Tokunou T, et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009;120:876-87.
25. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008;77:134-42. (Pubitemid 351195153)
26. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-4. (Pubitemid 27161245)
27. Schildknecht S, Bachschmid M, Baumann A, Ullrich V. COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells. FASEB J 2004;18:757-9.
28. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-25.
29. Song H, Song BW, Cha MJ, Choi IG, Hwang KC. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther 2010;10:309-19.
30. Tang J, Wang J, Zheng F, Kong X, Guo L, Yang J, et al. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 2010;339:107-18.
31. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 2004;16:349-60. (Pubitemid 38420055)
32. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8. (Pubitemid 34049148)
33. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132-40.
34. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9. (Pubitemid 36050963)
35. van Ramshorst J, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP, et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009;301:1997-2004.
36. Wang Y, Zhang D, Ashraf M, Zhao T, Huang W, Ashraf A, et al. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 2010;298:H275-86.
37. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005;96:151-63. (Pubitemid 40209362)
38. Yang Z, Arnet U, Bauer E, von Segesser L, Siebenmann R, Turina M, et al. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. Circulation 1994;89:2266-72.
39. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005;115:326-38. (Pubitemid 40385474)
40. Zhao W, Waggoner JR, Zhang ZG, Lam CK, Han P, Qian J, et al. The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci USA 2009;106:20776-81.